+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Horizon Pharma plc - logo

Horizon Pharma plc is a biopharmaceutical company focused on developing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases. The company markets 11 medicines through its orphan, rheumatology and primary care business units, including ACTIMMUNE, BUPHENYL, DUEXIS, RAVICTI, QUINSAIR and PENNSAID. Horizon Pharma Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland.

From
From
From
From
From
Graves' Ophthalmopathy - Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Ophthalmopathy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Interstitial Lung Disease Market Report 2025 - Product Thumbnail Image

Interstitial Lung Disease Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Antibody Contract Manufacturing Market, 2020 - 2030 - Product Thumbnail Image

Antibody Contract Manufacturing Market, 2020 - 2030

  • Report
  • January 2020
  • 305 Pages
  • Global
From
From
Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028 - Product Thumbnail Image

Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028

  • Report
  • April 2018
  • 200 Pages
  • Global
From
Tau Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Tau Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator